NCT06094413

Effects of Multicomponent Training on Sarcopenia

Name: Clinical Trial NCT06094413
Creator: Geisinger Clinic
Keywords: Sarcopenia, Multicomponent Training Intervention, behavioral, clinical trial

The Effects of an 8-week Multicomponent Training Program on Quality of Life, Fear of Falling, & Physical Performance in Community-Dwelling Older Adults With Probable Sarcopenia

Geisinger Clinic·ClinicalTrials.gov·behavioralNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Sarcopenia
Drug/Device/Intervention: Multicomponent Training Intervention
Study type: Interventional
Intervention type: behavioral

Sponsor & location

Primary sponsor: Geisinger Clinic

Timeline & enrollment

Phase: N/A
Start date: Dec 01, 2023
End date: May 01, 2024
Enrollment: 25 participants

Primary outcome

Sarcopenia Quality of Life (SarQoL) score,Falls Efficacy Scale-International (FES-I) score,Short Physical Performance Battery (SPPB) composite score

Summary

The purpose of the study is to determine whether community-dwelling older adults with probable sarcopenia (muscle loss) will experience improved patient-reported outcomes and physical performance after completing an 8-week multicomponent exercise training program when compared to a control group who does not complete the intervention. As an additional aim, subjects who participate in the exercise intervention will be asked about their experiences to identify factors that contribute to positive health behaviors in community-dwelling older adults.

ICD-10 classifications

Kaposi sarcomaHerniaTaeniasisTaenia saginata taeniasisDiaphragmatic hernia

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06094413
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06094413 through Pure Global AI's free database. This phase not specified trial is sponsored by Geisinger Clinic and is currently Not yet recruiting. The study focuses on Sarcopenia. Target enrollment is 25 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.